Ginkgo Bioworks (DNA)
(Delayed Data from NYSE)
$14.28 USD
+0.68 (5.00%)
Updated Aug 5, 2025 04:00 PM ET
Pre-Market: $14.23 -0.05 (-0.35%) 9:18 AM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DNA 14.28 +0.68(5.00%)
Will DNA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DNA
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know
DNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why
Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock?
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know
Other News for DNA
Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation | DNA Stock News
Ginkgo Bioworks (DNA) to Enhance EMSL Research with Automation Platform
Ginkgo Bioworks awarded $4.66M contract by PNNL
Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences ...
BlackRock, Inc. Expands Holdings in Ginkgo Bioworks Holdings Inc.